John Prybylski

9PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsAllergyRadiation therapyToxicology (incl. clinical toxicology)Agricultural molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study.

|Mar 24, 2026
Early exposure-response modeling of an interferon-beta monoclonal antibody (dazukibart) in adults with dermatomyositis.

John P Prybylski, Jing 'Daisy' Zhu, Christopher Banfield

|May 12, 2025
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose Selection.

Yeamin Huh, Ruolun Qiu, John Prybylski

|Jan 22, 2025
Operating Characteristics of the Simulated Healthy Participant Approach in Impaired Clearance Studies.

Sana Gupta, Vivek Purohit, Yuchen Wang

|Dec 02, 2024
Which Models are USEful?

John P Prybylski

|Aug 14, 2024
Indirect modeling of derived outcomes: Are minor prediction discrepancies a cause for concern?

John P Prybylski

Pageof 2

Frequent Collaborators

4 joint publications

Vivek S Purohit

3 joint publications

Yuchen Wang

1 joint publications

Jim H Hughes

1 joint publications

Vaishali Sahasrabudhe